Radiopharm Theranostics Ltd (RAD) — Cash Flow-to-Debt Ratio
Radiopharm Theranostics Ltd (RAD) has a Cash Flow-to-Debt Ratio of -0.55x as of December 2025, meaning its operating cash flow of AU$-22.67 Million could theoretically repay -1% of its total liabilities (AU$41.23 Million) in one year. Explore Radiopharm Theranostics Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Radiopharm Theranostics Ltd Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Radiopharm Theranostics Ltd across 5 annual periods. Also explore Radiopharm Theranostics Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Radiopharm Theranostics Ltd (2021–2025)
Year-by-year debt coverage analysis for Radiopharm Theranostics Ltd. For market capitalisation and broader financial context, see Radiopharm Theranostics Ltd (RAD) total market value.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.84x | AU$-36.65 Million | AU$43.61 Million | ▼ -63.4% |
| 2024 | -0.51x | AU$-22.98 Million | AU$44.68 Million | ▲ +34.9% |
| 2023 | -0.79x | AU$-23.20 Million | AU$29.37 Million | ▼ -62.8% |
| 2022 | -0.49x | AU$-9.91 Million | AU$20.42 Million | ▼ -133.2% |
| 2021 | -0.21x | AU$-32.91K | AU$158.14K | — |